期刊文献+

负载胃癌酸洗抗原树突状细胞诱导高效特异的抗胃癌细胞效应 被引量:9

Efficient and specific effects of tumor specific CTL induced by dendritic cells loaded with gastric carcinoma antigen
暂未订购
导出
摘要 目的 研究负载胃癌酸洗抗原树突状细胞 (DC)诱导的特异性CTL对胃癌细胞的杀伤效应。方法 酸洗涤法获得SGC790 1细胞膜抗原多肽 ,GM CSF、IL 4和TNF a体外诱导扩增DC并负载酸洗抗原 ,制备胃癌抗原特异性CTL ;用CytoTox 96TM检测其对SGC790 1体外杀伤效应。结果 负载胃癌抗原肽的DC诱导的特异性CTL对SGC790 1的杀伤率达 88 95 % ,显著高于LAK细胞的杀伤率 (P <0 0 5 )。且其对同种不同分化类型的胃癌细胞株MGC80 3、MNK2 8也有较高的杀伤效应 ,而对LOVO及HepG2肿瘤细胞株无显著杀伤作用 (P >0 0 5 )。结论 负载胃癌抗原的DC体外可诱导出高效而特异的抗胃癌效应 ,提示以DC为中心的肿瘤生物治疗可望提高胃癌综合治疗水平。 Objective To explore the cytotoxic effect of tumor specific cytotoxic T lymphocyte (CTL) induced by gastric cancer peptide pulsed DC on gastric cancer cells. Methods Peptide of gastric cancer strain (SGC7901) was obtained by citrate phosphate buffer elution . Peripheral blood mononuclear cell (PBMC) were cultured under the condition of GM CSF(1 000 U/ml)+IL 4(1 000 U/ml) + TNF α(100 ng/ml). The tumor antigen specific CTL was generated from activated autologous T cell by acid eluted peptide pulsed DC. And the cytotoxicity of CTL to SGC7901 was assayed by Cyto Tox96 TM kit in vitro . Different tumor cell lines and LAK cells were used as control in these experiments. Results The killing rate of SGC7901 by the antigen specific CTL reached at 88.95%, nearly twice as high as that of control . The CTL had much higher cytotoxicity to different differentiated type of gastric cancer cells such as MGC803 and MNK28, as compared with LOVO and HepG2 tumor cells( P <0 01) . Conclusion DC might have potential value in clinical biotherapy of gastric cancers.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2002年第10期1236-1238,共3页 Journal of Third Military Medical University
关键词 胃癌酸洗抗原 树突状细胞 细胞毒性淋巴细胞 胃癌 生物治疗 Dendritic cell cytotoxic T lymphocyte gastric cancer biotherapy
  • 相关文献

参考文献9

  • 1Nair S K,Synder D, Rouse B T,et al .Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts[J].Int J Cancer,1997,70(6):706-715.
  • 2Storkus W J, Zeh H J,Salter R D,et al. Identification of T-cell epitope: rapid isolation of class I-presented peptides from viable cells by mild acid elution[J]. J Immunother,1993,14(2):94-103.
  • 3朱学军,曹雪涛,于益芝,陈国友,万涛,马施华,唐华,章卫平.人外周血树突状细胞的体外扩增及鉴定[J].中国肿瘤生物治疗杂志,1997,4(4):302-306. 被引量:91
  • 4Peiper M, Goedegebuure P S,Eberlein T J. Generation of peptide-speific cytotoxic T lymphocytes using allogeneic dendritic cells capable of lysing human pancreatic cancer cells[J]. Surgery,1997 Aug,122(2):235-241.
  • 5Runnels H A, Moore J, Jensen P,et al. A structural transition in class II major histocomatibility complex proteins at mildly acidic pH[J]. J Exp Med,1996,183(1):127-136.
  • 6Sigal L J, Reiser H, Rock K L. The role of B7-1 and B7-2 costimulation for the generation of CTL responses in vivo[J]. J Immunol,1998,161(6):2 740-2 745.
  • 7Angevin E, Andre F, Zitvogel L. Antitumor cellular immunotherapy: the breakthrough of dendritic cells[J]. Bull Cancer,2000,87(1):107-115.
  • 8Maehara Y, Tomisaki S, Oda S,et al. Lymph node metastasis and relation to tumor growth potential and local immune response in advanced gastric cancer[J]. Int J Cancer,1997,74(2):224-228.
  • 9Kiertscher S M, Luo J, Dubinett S M,et al. Tumors promote altered maturation and early apoptosis of monocyte-derived dendritic cells[J]. J Immunol,2000,164(3):1 269-1 276.

共引文献90

同被引文献76

  • 1汪灏,余佩武,郝群,曾冬竹,张坤,王月禾,雷晓,饶芸,蔡志民.树突状细胞疫苗对胃癌患者术后免疫功能影响的初步观察[J].中华胃肠外科杂志,2004,7(4):301-304. 被引量:4
  • 2刘思纯,袁世珍,陈国帧.大肠癌组织树突状细胞与病理特征及预后的关系[J].中山医科大学学报,1996,17(4):260-263. 被引量:9
  • 3Ohashi M,Kanai f,Ueno H,et al.Adenovirus mediated p53 tumour suppressor gene therapy for human gastric cancer cells in vitro and in vivo.Gut,1999,44:366-371.
  • 4Ohashi M,Kanai F,Tanaka T,et al.In vivo adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-producing pancreatic cancer.Japanese Journal Of Cancer Esearch,1998,89:457-462.
  • 5Shibata M,Nezu T,Fujisaki S,et al.Clinical potential of biological response modifiers combined with chemothereapy for gastric cancer.Japanese experience.Dig Surg,2002,19:255-260.
  • 6Cerea K,Romano F,Bravo AF,et al.Phase IB study on prevention of surgery-induced immunodeficiency with preoperative administration of low-dose subcutaneous interleukin-2 in gastric cancer patients.J Surg Oncol,2001,78:32-37.
  • 7Morisaki T,Matsunaga H,Beppu K,et al.A combination of cyclosporin-A(CsA)and interferon-gamma(INF-gamma)induces apoptosis in human gastric carcinoma cells.Anticancer Res,2000,20:3363-3373.
  • 8Parmiani G,Rivoltini L,Andreola G,et al.Cytokines in cancer therapy.Immunol Lett,2000,74:41-44.
  • 9Tsunoda T,Tanimura H,Yamaue H.Tumor specific CTL therapy for advanced cancer and development for cancer vaccine.Hepatogastroenterology,1999,46:1287-1292.
  • 10Sasaki S,Ozeki I,Takekawa M,et al.Antibody treatment for cancer.Nippon Geka Gakkai Zasshi,2000,101:607-611.

引证文献9

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部